Skip to main content
BMC Psychiatry logoLink to BMC Psychiatry
. 2020 Jan 8;20:9. doi: 10.1186/s12888-019-2398-7

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

Sanne Y Smith-Apeldoorn 1,, Jolien K E Veraart 1,2, Jeanine Kamphuis 1, Antoinette D I van Asselt 3, Daan J Touw 4, Marije aan het Rot 5, Robert A Schoevers 1
PMCID: PMC6947821  PMID: 31914973

Correction to: BMC Psychiatry (2019) 19:375

https://doi.org/10.1186/s12888-019-2359-1

After publication of our article [1] we were notified that Fig. 1 was wrongly presented.

Fig. 1.

Fig. 1

Trial flowchart. Schematic overview of the study design. T: Number illustrates number of weeks after baseline

The correct figure and corresponding title is presented below:

The original article has been corrected.

Reference

  • 1.Smith-Apeldoorn SY, et al. Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial. BMC Psychiatry. 2019;19:375. doi: 10.1186/s12888-019-2359-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Psychiatry are provided here courtesy of BMC

RESOURCES